Menaka Paranathala

Oct 16, 2024 | onlinelibrary.wiley.com | Harry Clifford |Menaka Paranathala |Yujiang Wang |Rhys Thomas

VNS is a safe and effective therapy for drug-resistant epilepsy. Key brain areas implicated in VNS include the thalamus, amygdala, hippocampus, and insula, among others. Identifying markers of difference in response to VNS within DRE could explain heterogeneity in outcomes. Promising markers are present in imaging, neurophysiological, clinical, and biochemical data, but these are often underinvestigated.